We collected 1–3-mL blood samples from all patients with suspected septicemia, pneumonia, or meningitis; inoculated blood samples into
BACTEC bottles (Becton Dickinson,
https://www.bd.com); and incubated them in an automated
BACTEC 9050 Blood Culture System (Becton Dickinson) for a maximum of 5 days. We subcultured positive cultures on blood agar plates and confirmed isolates as
S. aureus by using catalase and coagulase tests. We classified cultures that grew
Bacillus spp., C
orynebacterium spp., and coagulase-negative
Staphylococcus as contaminated. We used standard methods to investigate other body fluid samples collected for microbiological tests (
20 (
link)). We used disc diffusion methods to determine antimicrobial drug susceptibility according to the Clinical and Laboratory Standards Institute guidelines (
21 ). We categorized all
S. aureus isolates resistant to cefoxitin as methicillin-resistant.
We defined
S. aureus bacteremia cases as clinically suspected cases of septicemia, pneumonia, meningitis, osteomyelitis, septic arthritis, pyomyositis, or abscess identified by using standardized criteria (
19 (
link)) in patients from whom
S. aureus was isolated from their blood.
Odutola A., Bottomley C., Zaman S.A., Lindsay J., Shah M., Hossain I., Ndiaye M., Osuorah C.D., Olatunji Y., Badji H., Ikumapayi U.N., Manjang A., Salaudeen R., Ceesay L., Jasseh M., Adegbola R.A., Corrah T., Hill P.C., Greenwood B.M, & Mackenzie G.A. (2019). Staphylococcus aureus Bacteremia in Children of Rural Areas of The Gambia, 2008–2015. Emerging Infectious Diseases, 25(4), 701-709.